Objective assessment of attention difficulties in adults with Attention-Deficit Hyperactivity Disorder (ADHD) - Objective assessment of attention difficulties in adult ADHD 1
Phase 1
- Conditions
- Attention-Deficit Hyperactivity Disorder (ADHD) in Adults
- Registration Number
- EUCTR2005-002897-31-GB
- Lead Sponsor
- orth Bristol NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Adults, ADHD diagnosis, normal hearing, normal or corrected to normal vision
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years)
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Current history of neurological and/or psychiatric disorders, history of movement disorders, epilepsy, current use of MAO inhibitors or coumarin anticoagulants, drug abuse, problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption, severe hypertension, cardiac arrhythmia, angina pectoris, hyperthyroidism, glaucoma, thyrotoxicosis, pregnancy, severe hand motor deficit
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To provide an objective tool for the diagnosis and treatment monitoring of ADHD.;Secondary Objective: To improve the diagnosis and treatment of ADHD in adulthood, and throught it, the quality of life of these patients and their families.;Primary end point(s): Normalisation of event-related brain potentials (ERPs), improved behavioural measures
- Secondary Outcome Measures
Name Time Method